2Chen GO, Shi XG, Tang W, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): As2O3 exerts dose dependent dual effects on APL cells[J]. Blood, 1997,89: 3 345.
3Gianni M,Koken MHM,Chelbi-Alix MK, et al. Combined arsenic and retinoic acid treatment enhances differentiation and apoptosis in arsenic resistant NB4 cells[J]. Blood, 1998,91:4300-4 310.
4Finaux P,Degos L. Differentiation therapy for acute promyelocytic leukemia[J]. N Engl J Med, 1997,337:1 076- 1 077.
